Alignment Healthcare Inc (NASDAQ:ALHC)’s traded shares stood at 2.3 million during the latest session, with the company’s beta value hitting 1.33. At the last check today, the stock’s price was $14.42, to imply a decrease of -14.01% or -$2.35 in intraday trading. The ALHC share’s 52-week high remains $21.06, putting it -46.05% down since that peak but still an impressive 64.22% since price per share fell to its 52-week low of $5.16. The company has a valuation of $2.85B, with an average of 3.63 million shares in intraday trading volume over the past 10 days and average of 2.86 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Alignment Healthcare Inc (ALHC), translating to a mean rating of 2.00. Of 10 analyst(s) looking at the stock, 0 analyst(s) give ALHC a Sell rating. 1 of those analysts rate the stock as Overweight while 3 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.01.
Alignment Healthcare Inc (NASDAQ:ALHC) trade information
After registering a -14.01% downside in the latest session, Alignment Healthcare Inc (ALHC) has traded red over the past five days. The 5-day price performance for the stock is -17.69%, and -19.22% over 30 days. With these gigs, the year-to-date price performance is 28.18%. Short interest in Alignment Healthcare Inc (NASDAQ:ALHC) saw shorts transact 10.48 million shares and set a 3.15 days time to cover.
The extremes give us $9 and $21 for target low and target high price respectively. As such, ALHC has been trading -45.63% off suggested target high and 37.59% from its likely low.
Alignment Healthcare Inc (ALHC) estimates and forecasts
The rating firms project that company’s revenue will grow 38.89% compared to the previous financial year.
Revenue forecast for the current quarter as set by 10 analysts is 949.72M. Meanwhile, for the current quarter, a total of 10 analyst(s) estimate revenue growth to 955.86M.Earnings reports from the last fiscal year show that sales brought in 681.29M and 692.43M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 39.40% before jumping 38.04% in the following quarter.
ALHC Dividends
Alignment Healthcare Inc has its next earnings report out on 2025-Feb-26. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Alignment Healthcare Inc (NASDAQ:ALHC)’s Major holders
Alignment Healthcare Inc insiders hold 7.15% of total outstanding shares, with institutional holders owning 90.05% of the shares at 96.99% float percentage. In total, 90.05% institutions holds shares in the company, led by GENERAL ATLANTIC, L.P.. As of 2024-06-30, the company held over 60.99 million shares (or 31.9518% of shares), all amounting to roughly $476.97 million.
The next major institution holding the largest number of shares is WARBURG PINCUS LLC with 17.92 million shares, or about 9.389% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $140.16 million.
We also have Fidelity Select Portfolios-Health Care Portfolio and Manager Directed Portfolios-Hood River Small-Cap Growth Fund as the top two Mutual Funds with the largest holdings of the Alignment Healthcare Inc (ALHC) shares. Going by data provided on Feb 28, 2025 , Fidelity Select Portfolios-Health Care Portfolio holds roughly 3.4 shares. This is just over 1.72% of the total shares, with a market valuation of $49.61 million. Data from the same date shows that the other fund manager holds a little less at 3.05, or 1.54% of the shares, all valued at about 44.52 million.
